GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IQVIA Holdings Inc (BSP:I1QV34) » Definitions » Cash Flow from Financing

IQVIA Holdings (BSP:I1QV34) Cash Flow from Financing : R$-1,855 Mil (TTM As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is IQVIA Holdings Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Dec. 2023, IQVIA Holdings paid R$1,122 Mil more to buy back shares than it received from issuing new shares. It spent R$759 Mil paying down its debt. It paid R$0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received R$0 Mil from paying cash dividends to shareholders. It spent R$176 Mil on other financial activities. In all, IQVIA Holdings spent R$2,058 Mil on financial activities for the three months ended in Dec. 2023.


IQVIA Holdings Cash Flow from Financing Historical Data

The historical data trend for IQVIA Holdings's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IQVIA Holdings Cash Flow from Financing Chart

IQVIA Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,132.84 -1,116.40 -6,983.80 -1,725.74 -1,871.72

IQVIA Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,012.36 453.15 461.10 -711.17 -2,057.92

IQVIA Holdings Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

IQVIA Holdings's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:

IQVIA Holdings's Cash from Financing for the quarter that ended in Dec. 2023 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R$-1,855 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IQVIA Holdings  (BSP:I1QV34) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

IQVIA Holdings's issuance of stock for the three months ended in Dec. 2023 was R$0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

IQVIA Holdings's repurchase of stock for the three months ended in Dec. 2023 was R$-1,122 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

IQVIA Holdings's net issuance of debt for the three months ended in Dec. 2023 was R$-759 Mil. IQVIA Holdings spent R$759 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

IQVIA Holdings's net issuance of preferred for the three months ended in Dec. 2023 was R$0 Mil. IQVIA Holdings paid R$0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

IQVIA Holdings's cash flow for dividends for the three months ended in Dec. 2023 was R$0 Mil. IQVIA Holdings received R$0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

IQVIA Holdings's other financing for the three months ended in Dec. 2023 was R$-176 Mil. IQVIA Holdings spent R$176 Mil on other financial activities.


IQVIA Holdings Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of IQVIA Holdings's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


IQVIA Holdings (BSP:I1QV34) Business Description

Traded in Other Exchanges
Address
2400 Ellis Road, Durham, NC, USA, 27703
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

IQVIA Holdings (BSP:I1QV34) Headlines

No Headlines